CTNNB1 mutations and/or the activation of the WNT/β-catenin signaling pathway downregulates the expression of CCL5 and impairs dendritic cell recruitment, thus promoting immune escape and resistance to ICIs in murine models of HCC [65]. Here, CTNNB1 is linked to hepatocellular carcinoma.